 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
5/3/24 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/5/23 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/13/22 Nolet Chris 4/A Director² 1:5K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/6/22 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/7/21 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/15/20 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
7/18/19 Nolet Chris 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
7/18/19 Nolet Chris 3 Director² 2:7K Revance Therapeutics, Inc. Revance Theraps, Inc.
| ____________ | | ¹ | Filing/Form Types: /A | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|
